Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Anika Therapeutics (ANIK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 705,690
  • Shares Outstanding, K 14,650
  • Annual Sales, $ 103,380 K
  • Annual Income, $ 32,550 K
  • 36-Month Beta 1.69
  • Price/Sales 6.78
  • Price/Cash Flow 19.28
  • Price/Book 3.04

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.09 +7.34%
on 07/11/17
50.25 -3.68%
on 07/05/17
+1.07 (+2.26%)
since 06/20/17
3-Month
42.51 +13.86%
on 05/04/17
50.25 -3.68%
on 07/05/17
+3.81 (+8.54%)
since 04/20/17
52-Week
41.38 +16.96%
on 11/03/16
53.50 -9.53%
on 08/01/16
-3.67 (-7.05%)
since 07/20/16

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics

The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics

ANIK : 48.41 (+0.50%)
FLXN : 23.55 (-0.25%)
RXDX : 8.80 (-4.35%)
VRX : 17.54 (+1.68%)
Anika Announces $5 Million Milestone Payment from U.S. Commercial Sales of MONOVISC

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology,...

ANIK : 48.41 (+0.50%)
4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings

Here is a look at four drug stocks including Anika (ANIK) with a Sell Rank and negative earnings ESP that should be avoided ahead of earnings.

ANIK : 48.41 (+0.50%)
JNJ : 136.84 (+1.21%)
NVS : 85.57 (+0.64%)
FLXN : 23.55 (-0.25%)
RXDX : 8.80 (-4.35%)
VRX : 17.54 (+1.68%)
New Strong Sell Stocks for July 11th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

LVLT : 58.28 (+0.99%)
ANIK : 48.41 (+0.50%)
BCS : 10.81 (+0.75%)
AVP : 3.63 (-0.27%)
CIR : 58.81 (-0.91%)
Anika to Present at the Singular Research Summer Solstice Conference on July 13, 2017

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology,...

ANIK : 48.41 (+0.50%)
Cartilage Repair/Regeneration Market Analysis By Treatment Modality, Application, Treatment Type, Site And Segment Forecasts, 2014 - 2025

Research and Markets has announced the addition of the "Cartilage Repair/Regeneration Market Analysis By Treatment Modality, By Application, By Treatment Type, By Site And Segment Forecasts, 2014 - 2025"...

ANIK : 48.41 (+0.50%)
SNN : 35.19 (+0.23%)
SYK : 147.16 (+0.64%)
OSIR : 6.8200 (+0.29%)
VCEL : 3.33 (+5.71%)
Viscosupplementation - North America Analysis and Market Forecasts, 2023

Research and Markets has announced the addition of the "MediPoint: Viscosupplementation - North America Analysis and Market Forecasts" report to their offering. This report analyzes and discusses the...

ANIK : 48.41 (+0.50%)
SKUNF : 14.3000 (unch)
Viscosupplementation Analysis and Market Forecasts, 2023

Research and Markets has announced the addition of the "MediPoint: Viscosupplementation - Global Analysis and Market Forecasts" report to their offering. Global viscosupplementation market was estimated...

ANIK : 48.41 (+0.50%)
SKUNF : 14.3000 (unch)
Facial Injectables Market to Reach $17.2 Billion by 2025 - Analysis By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers)

Research and Markets has announced the addition of the "Facial Injectables Market Analysis By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application...

ANIK : 48.41 (+0.50%)
AGN : 250.47 (+1.65%)
Global Facial Injectables (Botulinum Toxin, Hyaluronic Acid, Collagen, and Polymers and Particles) Market 2017-2025

Research and Markets has announced the addition of the "Global Facial Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...

ANIK : 48.41 (+0.50%)
AGN : 250.47 (+1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices that promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid, a naturally-occurring, biocompatible polymer found in the body. Due to...

See More

Support & Resistance

2nd Resistance Point 48.70
1st Resistance Point 48.43
Last Price 48.41
1st Support Level 47.82
2nd Support Level 47.48

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.